Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery

W. T. Godbey, Anthony Atala

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The principle of promoter-targeted gene delivery was used to direct the expression of reporter genes and inducible caspases to Cox-2-overexpressing cancer cells. The polycation poly(ethylenimine) was used in unmodified form to nonvirally deliver genes into cells, and targeting was achieved at the transcriptional level. Results demonstrated that reporter expression was reduced by an average of 89.8% in normal cells and cell lines not overexpressing Cox-2 when the strong cytomegalovirus promoter was replaced with the human Cox-2 promoter in delivered plasmids. Cocultures of normal and Cox-2-overexpressing cancer cells showed less than 0.5% reporter expression in normal fibroblast cells but over 35% reporter expression in PC3 prostate cancer cells. This targeting method was then used to direct the expression of inducible forms of caspases 3 and 9 to Cox-2-overexpressing cancer cells of the bladder and prostate. Following activation of the resulting caspase pro-forms, cells underwent apoptosis as evidenced by DNA fragmentation and cytoskeletal degradation. This result was also observed in cells resistant to apoptosis in terms of TNF-α initiation. Such directed apoptosis could eventually serve as a treatment for an entire class of Cox-2-overexpressing carcinomas.

Original languageEnglish
Pages (from-to)1519-1527
Number of pages9
JournalGene Therapy
Volume10
Issue number17
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

Apoptosis
Gene Expression
Neoplasms
Caspases
Prostatic Neoplasms
Caspase 9
DNA Fragmentation
Coculture Techniques
Cytomegalovirus
Reporter Genes
Urinary Bladder Neoplasms
Caspase 3
Genes
Plasmids
Fibroblasts
Carcinoma
Cell Line

Keywords

  • Apoptosis
  • Caspase
  • Cox-2
  • Expression targeting
  • Polyethylenimine
  • Transfection

ASJC Scopus subject areas

  • Genetics

Cite this

Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery. / Godbey, W. T.; Atala, Anthony.

In: Gene Therapy, Vol. 10, No. 17, 01.08.2003, p. 1519-1527.

Research output: Contribution to journalArticle

Godbey, W. T. ; Atala, Anthony. / Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery. In: Gene Therapy. 2003 ; Vol. 10, No. 17. pp. 1519-1527.
@article{4260ff0cce9a40e1adfd78c74b782baa,
title = "Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery",
abstract = "The principle of promoter-targeted gene delivery was used to direct the expression of reporter genes and inducible caspases to Cox-2-overexpressing cancer cells. The polycation poly(ethylenimine) was used in unmodified form to nonvirally deliver genes into cells, and targeting was achieved at the transcriptional level. Results demonstrated that reporter expression was reduced by an average of 89.8{\%} in normal cells and cell lines not overexpressing Cox-2 when the strong cytomegalovirus promoter was replaced with the human Cox-2 promoter in delivered plasmids. Cocultures of normal and Cox-2-overexpressing cancer cells showed less than 0.5{\%} reporter expression in normal fibroblast cells but over 35{\%} reporter expression in PC3 prostate cancer cells. This targeting method was then used to direct the expression of inducible forms of caspases 3 and 9 to Cox-2-overexpressing cancer cells of the bladder and prostate. Following activation of the resulting caspase pro-forms, cells underwent apoptosis as evidenced by DNA fragmentation and cytoskeletal degradation. This result was also observed in cells resistant to apoptosis in terms of TNF-α initiation. Such directed apoptosis could eventually serve as a treatment for an entire class of Cox-2-overexpressing carcinomas.",
keywords = "Apoptosis, Caspase, Cox-2, Expression targeting, Polyethylenimine, Transfection",
author = "Godbey, {W. T.} and Anthony Atala",
year = "2003",
month = "8",
day = "1",
doi = "10.1038/sj.gt.3302012",
language = "English",
volume = "10",
pages = "1519--1527",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "17",

}

TY - JOUR

T1 - Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery

AU - Godbey, W. T.

AU - Atala, Anthony

PY - 2003/8/1

Y1 - 2003/8/1

N2 - The principle of promoter-targeted gene delivery was used to direct the expression of reporter genes and inducible caspases to Cox-2-overexpressing cancer cells. The polycation poly(ethylenimine) was used in unmodified form to nonvirally deliver genes into cells, and targeting was achieved at the transcriptional level. Results demonstrated that reporter expression was reduced by an average of 89.8% in normal cells and cell lines not overexpressing Cox-2 when the strong cytomegalovirus promoter was replaced with the human Cox-2 promoter in delivered plasmids. Cocultures of normal and Cox-2-overexpressing cancer cells showed less than 0.5% reporter expression in normal fibroblast cells but over 35% reporter expression in PC3 prostate cancer cells. This targeting method was then used to direct the expression of inducible forms of caspases 3 and 9 to Cox-2-overexpressing cancer cells of the bladder and prostate. Following activation of the resulting caspase pro-forms, cells underwent apoptosis as evidenced by DNA fragmentation and cytoskeletal degradation. This result was also observed in cells resistant to apoptosis in terms of TNF-α initiation. Such directed apoptosis could eventually serve as a treatment for an entire class of Cox-2-overexpressing carcinomas.

AB - The principle of promoter-targeted gene delivery was used to direct the expression of reporter genes and inducible caspases to Cox-2-overexpressing cancer cells. The polycation poly(ethylenimine) was used in unmodified form to nonvirally deliver genes into cells, and targeting was achieved at the transcriptional level. Results demonstrated that reporter expression was reduced by an average of 89.8% in normal cells and cell lines not overexpressing Cox-2 when the strong cytomegalovirus promoter was replaced with the human Cox-2 promoter in delivered plasmids. Cocultures of normal and Cox-2-overexpressing cancer cells showed less than 0.5% reporter expression in normal fibroblast cells but over 35% reporter expression in PC3 prostate cancer cells. This targeting method was then used to direct the expression of inducible forms of caspases 3 and 9 to Cox-2-overexpressing cancer cells of the bladder and prostate. Following activation of the resulting caspase pro-forms, cells underwent apoptosis as evidenced by DNA fragmentation and cytoskeletal degradation. This result was also observed in cells resistant to apoptosis in terms of TNF-α initiation. Such directed apoptosis could eventually serve as a treatment for an entire class of Cox-2-overexpressing carcinomas.

KW - Apoptosis

KW - Caspase

KW - Cox-2

KW - Expression targeting

KW - Polyethylenimine

KW - Transfection

UR - http://www.scopus.com/inward/record.url?scp=0043026940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043026940&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302012

DO - 10.1038/sj.gt.3302012

M3 - Article

VL - 10

SP - 1519

EP - 1527

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 17

ER -